Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis: JACC Review Topic of the Week.
Document Type
Article
Publication Title
Journal of the American College of Cardiology
Abstract
The advance of therapies to reduce the stroke impact of asymptomatic carotid artery stenosis has proved difficult over the last decade. Disagreement concerning the underlying randomized control trials has limited entry into the care arena of endovascular therapies. Recently, advances in percutaneous therapies for carotid artery disease have been reported and provide a substantial database supporting the further incorporation of endovascular-based therapies in patients who need revascularization and meet selection criteria. With a second randomized control trial now published, it is time for a re-evaluation of endovascular therapy as a component of carotid artery care. This review describes the advances in the field in the last 5 years, clarifying the current position of these therapies in the care of the patient with asymptomatic carotid artery disease.
First Page
648
Last Page
656
DOI
10.1016/j.jacc.2019.11.054
Publication Date
2-18-2020
Recommended Citation
Beckman JA, Ansel GM, Lyden SP, Das TS. Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Feb 18;75(6):648-656. doi: 10.1016/j.jacc.2019.11.054. PMID: 32057380.